Active Ingredient History
A cholera vaccine is a vaccine that is effective at preventing cholera. For the first six months after vaccination it provides about 85 percent protection, which decreases to 50 percent or 62 percent during the first year. After two years the level of protection decreases to less than 50 percent. When enough of the population is immunized, it may protect those who have not been immunized. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Cholera (Phase 4)
Cholera Vaccines (Phase 2)
Colitis, Ulcerative (Phase 2)
Diarrhea (Phase 3)
Immunity (Phase 4)
Infections (Phase 1)
Kidney Transplantation (Phase 4)
Primary Prevention (Phase 3)
Vaccines (Phase 3)
Vibrio cholerae (Phase 4)
Vibrio Infections (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue